id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-E-0124-0006,FDA,FDA-2000-E-0124,Certificate Extending Patent Term from U.S. Patent and Trademark Office,Rule,Certificate Extending Patent Term,2007-10-23T04:00:00Z,2007,10,,,2025-07-22T20:28:07Z,,0,0,09000064804cf446
FDA-2000-E-0124-0005,FDA,FDA-2000-E-0124,U.S. Patent and Trademark Office to Perkins Coie LLP,Other,Letter(s),2007-04-13T04:00:00Z,2007,4,,,2025-07-22T20:27:06Z,,0,0,09000064804cf444
FDA-2000-E-0124-0004,FDA,FDA-2000-E-0124,FDA/CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2006-10-31T05:00:00Z,2006,10,,,2025-07-22T20:24:42Z,,0,0,09000064804cf442
FDA-2000-E-0124-0003,FDA,FDA-2000-E-0124,Docket Log,Other,List (LST),2006-06-16T04:00:00Z,2006,6,,,2025-07-22T20:22:54Z,,0,0,09000064804cf441
FDA-2000-E-0124-0002,FDA,FDA-2000-E-0124,"Determination of Regulatory Review Period for Purposes of Patent
Extension; ALAMAST",Notice,General Notice,2006-03-24T05:00:00Z,2006,3,2006-03-22T05:00:00Z,2006-05-23T03:59:59Z,2025-07-19T00:02:12Z,,0,0,09000064804cf43f
FDA-2000-E-0124-0001,FDA,FDA-2000-E-0124,Letter from FDA to U.S. Patent and Trademark Office,Other,Letter(s),2006-02-27T05:00:00Z,2006,2,,,2025-07-18T23:58:31Z,,0,0,09000064804cf424